Zydus Wellness appoints Kapil Sharma as CRO effective September 1, 2026
- Zydus Wellness appoints Kapil Sharma as CRO for India and Indian subcontinent
- Appointment effective September 1, 2026, approved by Board of Directors
- Sharma brings 28+ years experience, including 25 years at P&G
- Previously served as VP-Gillette, India and Indian subcontinent

*this image is generated using AI for illustrative purposes only.
Zydus Wellness Limited has appointed Kapil Sharma as its Chief Revenue Officer (India and Indian subcontinent), effective September 1, 2026. The Board of Directors approved the appointment following the recommendation of the Nomination and Remuneration Committee.
Leadership appointment details
The following table summarises the key details of the appointment:
| Parameter | Details |
|---|---|
| Appointee | Kapil Sharma |
| New Role | Chief Revenue Officer (India and Indian subcontinent) |
| Effective Date | September 1, 2026 |
| Previous Role | VP at Gillette within P&G |
Sharma brings over 28 years of experience to the role, including 25 years with Procter & Gamble. He most recently served as VP-Gillette, India and Indian subcontinent, leading the grooming portfolio comprising Gillette, Venus, and Braun. Earlier in his career, he worked with Asea Brown Boveri for three years.
He holds an MBA in Marketing from S.P. Jain Institute of Management & Research, Mumbai, and a Bachelor of Electrical Engineering from the Institute of Engineering & Technology, Lucknow.
Historical Stock Returns for Zydus Wellness
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.40% | +3.37% | -8.53% | +37.26% | +30.85% | +14.16% |
How is Zydus Wellness expected to leverage Kapil Sharma's FMCG expertise to accelerate revenue growth in the competitive Indian wellness market?
What specific strategic shifts or new product initiatives might Sharma introduce given his background in leading the Gillette and Braun grooming portfolios?
Could this appointment signal a broader strategic pivot for Zydus Wellness towards mass-market consumer goods rather than just niche wellness products?


































